Tags : Pancreatic Cancers

Genentech Signs a Clinical Trial Collaboration with Arcus for Colorectal

Shots: The companies collaborate for the evaluation of novel candidates with Arcus’s AB928 utilizing the MORPHEUS P-Ib/II platform with upfront randomization versus control groups in two studies. The companies will supply its anti-cancer agents and will jointly find the studies The two studies are: The first study will assess AB928 + Tecentriq + regorafenib, Tecentriq […]Read More